The expression of the murine interleukin (IL)-2 receptor ␣ chain/CD25 is strongly induced at the transcriptional level after T cell activation. We show here that nuclear factor of activated T cell (NF-AT) factors are involved in the control of CD25 promoter induction in T cells. NFATp and NF-ATc bind to two sites around positions Ϫ 585 and Ϫ 650 located upstream of the proximal CD25 promoter. Immediately 3 Ј from these NF-AT motifs, nonconsensus sites are located for the binding of AP-1-like factors. Mutations of sites that suppress NF-AT binding impair the induction and strong NF-ATp-mediated transactivation of the CD25 promoter in T cells. In T lymphocytes from NF-ATp-deficient mice, the expression of CD25 is severely impaired, leading to a delayed IL-2 receptor expression after T cell receptor (TCR)/CD3 stimulation. Our data indicate an important role for NF-AT in the faithful expression of high affinity IL-2 receptors and a close link between the TCR-mediated induction of IL-2 and IL-2 receptor ␣ chain promoters, both of which are regulated by NF-AT factors.
T he high affinity IL-2 receptor consists of three individual polypeptides, the ␣ , ␤ , and ␥ chains. Although the ␤ and ␥ chains are shared by other lymphokine receptors, the ␣ chain (CD25) is restricted to the IL-2 receptor, and is expressed by a variety of lymphoid cells (for review see reference 1). The induction of CD25 in T cells is controlled at the transcriptional level through two DNA sequence elements, a proximal promoter/enhancer spanning the nucleotides between positions Ϫ 54 and Ϫ 584 in the mouse and Ϫ 64 and Ϫ 276 in humans, and a distal enhancer spanning ‫ف‬ 80 nucleotides around position Ϫ 1350 in the mouse and Ϫ 3750 (or Ϫ 4150, according to another nomenclature) in the human CD25 gene (2) (3) (4) (5) (6) . The activity of the promoter is rapidly induced by TCR-mediated signals or IL-1, and is controlled by an array of transcription factors, in particular by nuclear factor (NF)-B, Elf-1, SRF, and HMG I(Y). The induction of the distal enhancer is controlled by IL-2, which induces signal transducer and activator of transcription (Stat)5, a member of the family of Stat transcription factors. Stat5 binds in concert with Elf-1, HMG I(Y), and GATA factors to multiple sites of the distal enhancer and contributes to its IL-2-mediated full expression in activated peripheral T lymphocytes (4) (5) (6) .
Nuclear factor of activated T cell (NF-AT) factors comprise a family of transcription factors that contribute to the induced expression of numerous lymphokine and receptor genes in T cells. Similar to NF-B factors, the nuclear translocation and activity of NF-AT factors is stimulated by TCR-mediated signals (for review see reference 7). The DNA-binding domains of NF-AT and NF-B/Rel factors share a common architecture (8) and, therefore, recognize overlapping DNA sequence motifs. These common properties between NF-AT and NF-B (a major regulator of the CD25 promoter), and reports on the inhibition of CD25 expression by cyclosporin A (9) (an inhibitor of phosphatase calcineurin and, therefore, of nuclear translocation of NF-AT; reference 7), prompted us to investigate whether NF-AT factors participate in CD25 promoter control. We show here that NF-ATp and NF-ATc bind to two sites located immediately upstream of the proximal CD25 promoter. Mutations within the NF-AT sites that suppress NF-AT binding impair CD25 promoter induction. Accordingly, the induction of CD25 is markedly delayed in T cells from NF-ATp-deficient mice. These findings implicate an important role for NF-AT factors in the inducible The first two authors contributed equally to this paper. expression of high affinity IL-2 receptors after T cell activation.
Materials and Methods
Cell Culture, Construction, and Transfection of CD25 Promoter Luciferase Plasmids. Murine El4 T thymoma cells and human Jurkat T leukemia cells were grown in RPMI medium containing 5% FCS. 2 ϫ 10 7 cells were transfected using the DEAE dextran protocol with 2.5 g DNA of the CD25 promoter-luciferase reporter constructs alone or 0.5-2.5 g DNA of reporter constructs (as indicated in the figure legends) along with 2 g of a pLGP3-based vector expressing full-length murine NF-ATp (NF-AT1-C; reference 10) or an RSV-LTR vector expressing human NFATc. Human 293 embryonic kidney cells were cultured in DMEM and transfected using a calcium phosphate transfection protocol. The luciferase reporter gene construct contains the wild-type murine CD25 promoter spanning the nucleotides up to position Ϫ 2556 (4). Mutations in one or both of the NF-ATp binding sites around positions Ϫ 585 and Ϫ 650 were introduced into the promoter fragment from ϩ 1 to Ϫ 800 using the QuikChange TM site-directed mutagenesis kit (Stratagene Corp., La Jolla, CA) according to the manufacturer's instructions.
The following oligonucleotides were used for the mutagenesis of NF-AT sites:
The underlined nucleotides indicate the mutations.
Immunofluorescence and Flow Cytometry. For Ab stainings, 2-8 ϫ 10 5 cells were incubated on ice with mAbs at saturating concentrations. Fluorescein-and PE-labeled mAbs (Pharmingen, San Diego, CA) were used for two-and three-color immunofluorescence. For three-color flow cytometry, cells were stained first with biotinylated mAbs (PharMingen) for 15 min and were subsequently incubated with streptavidin-Red 670 (GIBCO BRL, Eggenstein, Germany) and FITC-and PE-labeled mAbs for 15 min. Results obtained after analysis on a FACScan ® flow cytometer (Becton Dickinson, Mountain View, CA) using Lysys II software (Becton Dickinson) are shown as log dot-plots or histograms.
DNase I Footprint Protection Assays and EMSAs. In DNase I footprint protection assays, end-labeled DNA probes were prepared using [ ␥ -32 P]ATP and polynucleotide kinase. 10 4 cpm ( ‫ف‬ 0.2 ng) of the following DNA fragments from the murine CD25 promoter (4) were used: ( a ) the HindIII-SacII fragment spanning the nucleotides from position ϩ 94 to Ϫ 268; and ( b ) the SacII-BglII fragment spanning the nucleotides from Ϫ 268 to Ϫ 801. Fragment ( a ) was recut with EspI, and fragment ( b ) with DraI generating DNA fragments of ‫ف‬ 150-300 bp. These were incubated for 60 min with a bacterially expressed glutathione S -transferase (GST)-NF-ATp protein (11) containing the DNAbinding domain of murine NF-ATp. The samples were processed and fractionated on 6% polyacrylamide, 42% urea-sequencing gels.
Electromobility shift assays (EMSAs) were performed as previously described (11), using 2 g nuclear proteins and 0.5 g poly [d(I-C)]. In supershift EMSAs, 0.5 g of either an NF-ATp-specific Ab (Cat. no. 06-348; UBI) or an NF-ATc-specific mAb (7A6) (12) were added to the incubations. When the DNA binding of GST-NF-ATp was tested, 0.5-1.5 g of bacterial proteins prepared by affinity column chromatography (11) were incubated along with 0.5 g poly [d(I-C)]. The following oligonucleotides were used as probes:
The small letters indicate linker nucleotides.
Results and Discussion
To determine whether the CD25 promoter is a target for NF-AT, we cotransfected a CD25 promoter-driven luciferase reporter gene with NF-ATp-and NF-ATc-specific expression vectors into El4 T and 293 cells. Treatment of 293 cells with TPA plus ionomycin (T ϩ I) led to a Ͻ 2-fold, and treatment of El4 cells with T ϩ Con A led to an 8-9-fold, induction of activity of CD25 promoter spanning the nucleotides up to position Ϫ 2556 (4), and to a 12-fold induction of a shorter CD25 promoter reaching up to Ϫ 800. Cotransfection of an NF-ATp expression vector into El4 cells resulted in a strong, 40-fold induction of activity of the longer CD25 promoter and in an up to 60-fold induction of the shorter CD25 promoter fragment after T ϩ Con A treatment of cells (Fig. 1) . Cotransfection with the NF-ATc vector gave rise to only a slight increase in promoter activity. In 293 cells, the overexpression of both NF-AT factors resulted in a six-to ninefold increase in CD25 promoter activity (Fig. 1) .
To demonstrate the binding of NF-ATp to the CD25 promoter, GST-NF-ATp encoding its DNA-binding domain was incubated with DNA fragments containing the first 800 bp of the promoter region in DNase I footprint protection assays. Two prominent footprints were detected, spanning the nucleotides from Ϫ 577 to Ϫ 587 and Ϫ 639 to Ϫ 658, respectively (Fig. 2 A ) . These comprise the NF-AT "core" binding sequence TGGAA (7) in opposite orientations (Fig. 2 B ) . When probes of these oligonucleotides were incubated with GST-NF-ATp in EMSAs, both probes were bound by NF-ATp, whereas a third probe spanning the unprotected nucleotides from Ϫ 619 to Ϫ 636 was unable to bind (Fig. 2 C , lanes 13-15 ) . Using nuclear proteins from murine splenocytes, the generation of typical inducible NF-AT complexes was detected with the Ϫ 639/ Ϫ 658 probe (Fig. 2 C , lanes 1-6) and, although far more weakly, with the Ϫ577/Ϫ587 probe (Fig. 2 C,  lanes 7-12) . The generation of these complexes was enhanced after induction of cells with TϩI (lanes 1, 2, 7 , and 8) and efficiently competed with a 100-fold molar excess of the distal IL-2 NF-AT site (Fig. 2 C, lanes 6 and 12) . Moreover, the complexes were supershifted in EMSAs using NFATp-and NF-ATc-specific Abs (lanes 3, 4, 9, and 10) .
The Ϫ639/Ϫ658 site corresponds to a high-affinity NF-AT binding site. This could be seen best in EMSA competition assays comparing the binding of NF-AT factors in nuclear protein preparations from TϩI-induced Jurkat cells to this site and the distal NF-AT site of the murine IL-2 promoter (Fig. 2 D) . Although 5-10 ng of the Ϫ639/Ϫ658 site was sufficient to suppress almost all NF-AT binding, 10-50 ng of the distal IL-2 NF-AT site was necessary to see the same effect (Fig. 2 D, lanes 6-11) . 50 ng of an AP-1 site was also able to suppress NF-AT complex formation, whereas the same amount of the upstream promoter site, i.e., an efficient octamer but poor AP-1 site from the IL-2 promoter (11), was without effect on factor binding (Fig. 2  D, lanes 12-15) . In contrast to the Ϫ639/Ϫ658 site, the Ϫ577/Ϫ587 NF-ATp binding site is a low-affinity NF-AT site (Fig. 2 C, lanes 7-12; note that lanes 7-12 were exposed five times longer than lanes 1-6).
To demonstrate a functional role for the two NF-ATp sites, we introduced mutations into the NF-AT motifs of each site, or into both sites, in the context of the 800-bp wild-type CD25 promoter fragment. These mutations led to a loss of NF-AT binding in EMSAs using nuclear proteins from induced Jurkat cells (see Fig. 2 D, lanes 18-20) 12 and 15) . In lane 14, a probe of the Ϫ610/Ϫ636 site was used as a control. 2 g of nuclear proteins from uninduced splenocytes (Ϫ) or splenocytes induced for 2 h with TϩI (ϩ) were incubated in the absence or presence of 0.5 g NFATc-or NF-ATp-specific Abs, or in the presence of a 200-fold molar excess of homologous unlabeled probes or distal IL-2 NF-AT site as indicated. Note that the autoradiograph of lanes 1-6 was exposed for 16 h, and that of lanes 7-12 for 3 d. NS, nonspecific complex. Free probes are cut off. (D) EMSAs of the Ϫ639/Ϫ658 site using nuclear proteins from Jurkat cells. A probe of the Ϫ639/Ϫ658 site was incubated with 2 g of nuclear proteins from Jurkat cells treated with TϩI in the absence or presence of 100 ng/ml cyclosporin A (CsA). For competition the following DNAs were used: 5-50 ng of the cold Ϫ639/Ϫ658 site and the distal IL-2 NF-AT site, or 10 and 50 ng of the proximal IL-2 octamer site (11) and a consensus AP-1 site. In lanes 16 and 17, 0.5 g of NF-AT-specific Abs were added. In lanes 18-20, a Ϫ632/Ϫ667 probe mutated in the NF-AT site (see oligonucleotide a in Materials and Methods) was incubated without or with NF-AT-specific Abs.
or GST-NF-ATp (data not shown). When the mutated CD25 promoter/luciferase constructs were transfected into El4 T cells alone or with an NF-ATp expression vector their induction was severely impaired compared with the wild-type promoter. The TϩCon A-mediated 16-fold induction of the 800-bp CD25 promoter fragment was almost abolished (Fig. 3 A) and its Ͼ25-fold transactivation by NF-ATp was reduced to a 2-3-fold increase for the mutated promoter (Fig. 3 B) .
The importance of NF-ATp sites for the CD25 expression is underlined by defects in the CD25 surface expression on LN T cells from NF-ATp Ϫ/Ϫ mice established in our laboratory (13) . When LN T cells from wild-type mice were stimulated with plate-bound ␣-CD3 Abs for 2-24 h in vitro, a marked increase of CD25 surface expression was detected after 6-12 h, which became even more pronounced after 24 h. Due to the strong stimulation of the CD25 promoter by secreted IL-2 (2), Ͼ50% of T cells express large amounts of CD25 48 h after stimulation (Fig. 4) . On NF-ATp Ϫ/Ϫ LN T cells, CD25 expression was found to be distinctly delayed, becoming clearly detectable only 24 h after induction in spite of high, unimpaired IL-2 production of NF-ATp Ϫ/Ϫ T cells (13) . In addition, fewer cells expressed high levels of CD25 after induction for 48 h (Fig. 4) .
The two NF-ATp binding sites are located near the CD25 promoter and therefore appear to be involved in the rapid induction of the murine CD25 gene in resting T cells. The core sequences of these sites, TGGAA, differ slightly from the AGGAAAA core motifs of the IL-2 and IL-4 promoters and are the strongest NF-ATp binding sites in the human GM-CSF enhancer (14) . As indicated in Fig.  2 B, 7-9 bp 3Ј to the NF-AT motifs are situated TPAresponsive element-like sequences that might allow the concerted binding of AP-1 and NF-AT. In EMSAs we detected a specific binding of GST-c-Jun to both sites (data not shown), but it remains to be shown which proteins of the AP-1 family bind and regulate the CD25 promoter in vivo.
Finally, it should be pointed out that several properties of NF-ATp Ϫ/Ϫ mice, such as the impaired clonal deletion of T cells and expansion of lymphoid organs (13, 15, 16) , are shared by the mice deficient for IL-2 and IL-2 receptors (17) (18) (19) . We assume that the impaired CD25 expression might contribute to the development of this phenotype in NF-ATp Ϫ/Ϫ mice, which is reminiscent of other mice with defects in the IL-2 signaling system. 
